Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2013-07-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 50

Registration Number: NCT00001110

Locations: 🇺🇸
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia, Pennsylvania, United States
🇺🇸
Univ. of Cincinnati CRS, Cincinnati, Ohio, United States
🇺🇸
NY Univ. HIV/AIDS CRS, New York, New York, United States

and more 2 locations

Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs

Completed

Conditions: HIV Infections
Peripheral Nervous System Disease

First Posted Date: 2001-08-31

Last Posted Date: 2013-07-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 100

Registration Number: NCT00017771

Locations: 🇺🇸
Univ of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
UCLA CARE Ctr, Los Angeles, California, United States
🇺🇸
Univ of Hawaii, Honolulu, Hawaii, United States

and more 15 locations

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2013-07-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 240

Registration Number: NCT00014937

Locations: 🇮🇹
Spedali Civili - Carosi, Brescia, Italy
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
🇺🇸
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States

and more 34 locations

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Not Applicable

Completed

Conditions: HIV Infections
Lipodystrophy
Hyperinsulinemia

First Posted Date: 2001-08-31

Last Posted Date: 2013-07-22

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 105

Registration Number: NCT00015691

Locations: 🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States
🇺🇸
Ohio State Univ Hosp Clinic, Columbus, Ohio, United States
🇺🇸
Vanderbilt Univ Med Ctr, Nashville, Tennessee, United States

and more 31 locations

A Study of Immune System Activity in Healthy Adults

Completed

Conditions: HIV Infections
HIV Seronegativity

First Posted Date: 2001-08-31

Last Posted Date: 2008-07-30

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 48

Registration Number: NCT00014053

Locations: 🇺🇸
Case Western Reserve Univ, Cleveland, Ohio, United States
🇺🇸
Univ of California San Francisco, San Francisco, California, United States
🇺🇸
Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States

and more 6 locations

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Drug: Lamivudine/Zidovudine
Drug: Nelfinavir mesylate
Drug: Aldesleukin

First Posted Date: 2001-08-31

Last Posted Date: 2015-03-09

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 398

Registration Number: NCT00006441

Locations: 🇺🇸
University of Alabama- Birmingham, Birmingham, Alabama, United States
🇺🇸
Rick Hecht, San Francisco, California, United States

Steroid Withdrawal in Pediatric Kidney Transplant Recipients

Phase 2

Terminated

Conditions: End-Stage Renal Disease

Interventions: Drug: Basiliximab
Drug: Cyclosporine
Drug: Tacrolimus
Drug: Sirolimus
Drug: Methylprednisolone
Drug: Prednisone
Drug: Bactrim

First Posted Date: 2001-08-31

Last Posted Date: 2016-10-21

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 274

Registration Number: NCT00023244

Locations: 🇺🇸
University of Florida Health Science Center, Jacksonville, Florida, United States
🇺🇸
The Children's Hospital of Buffalo, Buffalo, New York, United States
🇺🇸
Westchester Medical Center, Valhalla, New York, United States

and more 16 locations

A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2013-05-06

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 30

Registration Number: NCT00001060

Locations: 🇺🇸
Duke Univ Med Ctr, Durham, North Carolina, United States

A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 72

Registration Number: NCT00000889

Locations: 🇦🇷
Hospital F.J. Muniz C601-050 CRS, Ciudad de Buenos Aires, Buenos Aires, Argentina
🇦🇷
Hospital Italiano de Buenos Aires C601-020 CRS, Ciudad de Buenos Aires, Buenos Aires, Argentina
🇦🇷
Hospital de Clinicas 'Jose de San Martin' C601-040 CRS, Ciudad de Buenos Aires, Buenos Aires, Argentina

and more 1 locations

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 90

Registration Number: NCT00005762

Locations: 🇺🇸
Stanford CRS, Palo Alto, California, United States
🇺🇸
University of Colorado Hospital CRS, Aurora, Colorado, United States
🇺🇸
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy